First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: Results of the XaNADU-ACS Trial.
Journal of Thrombosis and Haemostasis.
Times cited: 51
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: The XaNADU-PCI pilot.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 43